Latest Breaking News On - Geoff nash - Page 12 : vimarsana.com

Synairgen plc: Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022

Analysis of 60 and 90-day data from Phase 3 SPRINTER trial in hospitalised COVID-19 patients showed that SNG001 reduced risk of recognised Long COVID symptoms Company to present full analysis

United statesNamrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldChris brightlingLucy featherstoneNumis securities limited joint brokerHead of communications

Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022

Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNamrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldChris brightlingLucy featherstoneNumis securities limited joint brokerHead of communications

Investegate |Poolbeg Pharma PLC Announcements | Poolbeg Pharma PLC: HC Wainwright Global Investment Conference

Investegate announcements from Poolbeg Pharma PLC, HC Wainwright Global Investment Conference

New yorkUnited statesCity ofUnited kingdomCathal frielRichard chambersMelanie toyne sewellCharlie beesonNiall gilchristJeremy skillingtonIan oconnellNigel birksAnthony farrellPoolbeg pharmaLinkedin poolbegpharmaSam butcher

Synairgen plc: Synairgen announces positive findings from analysis of lung samples from the SG015 trial of SNG001 in virally infected COPD patients

Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces positive

United statesNational harborNamrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneMicrobial resistance congressNumis securities limited joint broker

Investegate |Synairgen plc Announcements | Synairgen plc: Company Announce Collaboration on UNIVERSAL Trial

Investegate announcements from Synairgen plc, Company Announce Collaboration on UNIVERSAL Trial

United kingdomNamrata taakGeoff nashMary conwayTom wilkinsonRichard marsdenDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneNumis securities limited joint brokerHead of communications